1. Home
  2. VTVT vs PIII Comparison

VTVT vs PIII Comparison

Compare VTVT & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTVT
  • PIII
  • Stock Information
  • Founded
  • VTVT 2015
  • PIII 2015
  • Country
  • VTVT United States
  • PIII United States
  • Employees
  • VTVT N/A
  • PIII N/A
  • Industry
  • VTVT Biotechnology: Pharmaceutical Preparations
  • PIII Medical/Nursing Services
  • Sector
  • VTVT Health Care
  • PIII Health Care
  • Exchange
  • VTVT Nasdaq
  • PIII Nasdaq
  • Market Cap
  • VTVT 38.8M
  • PIII 32.2M
  • IPO Year
  • VTVT 2015
  • PIII N/A
  • Fundamental
  • Price
  • VTVT $14.05
  • PIII $0.21
  • Analyst Decision
  • VTVT Strong Buy
  • PIII Buy
  • Analyst Count
  • VTVT 1
  • PIII 3
  • Target Price
  • VTVT $35.00
  • PIII $2.38
  • AVG Volume (30 Days)
  • VTVT 8.5K
  • PIII 5.4M
  • Earning Date
  • VTVT 03-12-2025
  • PIII 11-12-2024
  • Dividend Yield
  • VTVT N/A
  • PIII N/A
  • EPS Growth
  • VTVT N/A
  • PIII N/A
  • EPS
  • VTVT N/A
  • PIII N/A
  • Revenue
  • VTVT $1,000,000.00
  • PIII $1,476,630,000.00
  • Revenue This Year
  • VTVT N/A
  • PIII $21.45
  • Revenue Next Year
  • VTVT N/A
  • PIII N/A
  • P/E Ratio
  • VTVT N/A
  • PIII N/A
  • Revenue Growth
  • VTVT 11011.11
  • PIII 25.38
  • 52 Week Low
  • VTVT $7.38
  • PIII $0.18
  • 52 Week High
  • VTVT $30.99
  • PIII $1.35
  • Technical
  • Relative Strength Index (RSI)
  • VTVT 46.82
  • PIII 43.13
  • Support Level
  • VTVT $13.90
  • PIII $0.19
  • Resistance Level
  • VTVT $14.35
  • PIII $0.29
  • Average True Range (ATR)
  • VTVT 0.58
  • PIII 0.03
  • MACD
  • VTVT 0.03
  • PIII 0.00
  • Stochastic Oscillator
  • VTVT 42.61
  • PIII 14.29

About VTVT vTv Therapeutics Inc.

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

Share on Social Networks: